2. Present Major Points in English (with necessary Chinese explanation); 3. PPT with contribution of each member; 4. Deadline: 11th Jun. Sent to E-mail: ilmare13007@163.com 百合固金汤对结核 Regulations of Bai He Regulation of Baihe Gu 杆菌感染后巨噬细 Gu Jin Tang Drug- Jin Decoction 胞自噬功能的调节 serum on autophagy Medicated-serum on 作用 in macrophages Autophagy in 【摘要】 目的 观 infected by Macrophages with 察百合固金汤对巨 Mycobacterium Mycobacterium 噬细胞内自噬功能 tuberculosis tuberculosis Infection 的调节作用,以探 [Abstract] Research [Abstract] Objective: 寻其可能的抗结核 on regulations of Bai To explore the acting 分枝杆菌作用机制 He Gu Jin Tang mechanism of Baihe Gu 。 Drug-serum on Jin Decoction against autophagy in mycobacterium macrophages in order tuberculosis through to definite the possible observation of its mechanism of this regulation on autophagy decoction against in macrophages. Mycobacterium tuberculosis. 方法 以百合固金汤 Bai He Gu Jin Tang Methods: This study used medicated-serum of 含药血清干预感染结 Drug-serum interfered RAW264.7 Baihe Gu Jin Decoction 核分枝杆菌的 to interfere with RAW264.7巨噬细胞, macrophages infected RAW264.7 macrophages 0h、6h、12h、24h、 by Mycobacterium infected with tuberculosis. After 0h, mycobacterium 36h后RT-QPCR法检 6h, 12h, 24h and 36h, tuberculosis, employed 测干预前后巨噬细胞 detecting the mRNA RT-QPCR to detect the atg5、atg7、atg8、 expression of atg5, atg7, mRNA expressions of atg12表达变化;12h、atg8, atg12 by RT- atg5, atg7, atg8 and atg12 24h、36h后Western QPCR; After 12h, 24h 0h, 6h, 12h, 24h and 36h Blot法检测干预前后 and 36h, detecting the after intervention respectively, and adopted 巨噬细胞内自噬相关 protein expression of Western Blot to testify 蛋白LC3-Ⅱ的表达 LC3-Ⅱ by Western the autophagy-relevant 差异;12h、24h、 Blot and DNA content protein expression of 36h后QPCR法检测 of Mycobacterium LC3-Ⅱand QPCR to tuberculosis in 用药前后胞内结核分 quantify the DNA content macrophages by of Mycobacterium 枝杆菌DNA含量。 QPCR respectively. tuberculosis 12h, 24h and 36h later correspondingly. 结果 药物干预24h后, Compared to control Results: Compared with 用药组巨噬细胞atg5、 group, the Bai He Gu Jin control group, there was atg7、atg8、atg12表达 Tang drug-serum group significant increase in both 量出现不同程度增加 significantly increased the the mRNA expressions of (P<0.05),自噬特异性 mRNA expression of atg5, atg5, atg7, atg8 and atg12 of 蛋白LC3-Ⅱ表达量亦显 atg7, atg8, atg12 and the macrophages (P<0.05) and 著增高(P<0.05);药物 protein expression of the specific autophagy 干预36h后,在自噬特 LC3-Ⅱ after 24h(P<0.05). protein expression of LC3- 异性蛋白LC3-Ⅱ表达量 While after 36h, we found Ⅱin the medicated-serum 显著增高(P<0.05)的同 Bai He Gu Jin Tang group 24h after 时检测到胞内结核分枝 drug-serum significantly intervention (P<0.05); while, 杆菌DNA含量明显减少 up-regulated the protein notable up-regulated (P<0.05)。 expression of LC3- protein expression of LC3- Ⅱ(P<0.05), and down- Ⅱ(P<0.05) was detected to regulated the DNA coexist with distinct down- content of Mycobacterium regulated DNA content of tuberculosis in Mycobacterium tuberculosis macrophages (P<0.05). in macrophages (P<0.05) 36h after intervention. 结论 百合 All the results come Conclusion: Baihe 固金汤可能 to the conclusion Gu Jin Decoction 通过激活细 that Bai He Gu Jin may assist in treating 胞自噬现象 Tang maybe treat tuberculosis through 发挥抗结核 the tuberculosis by activating autophagy 的作用。 activating in macrophages. 【关键词】 autophagy in [Keywords] Baihe 百合固金汤 macrophages. Gu Jin Decoction; ;自噬;结 [Key words] Bai He Autophagy; 核分枝杆菌 Gu Jin Tang; Mycobacterium ;巨噬细胞 Autophagy; tuberculosis; Mycobacterium Macrophages tuberculosis; Macrophages Effect of Xuefu Zhuyu Decoction on endothelial function in 血府逐瘀汤对冠心病高同型 hyperhomocysteinemia of Clinical Observation of Xuefu Zhuyu Decoction Effect on Endothelial Function 半胱氨酸血症血管内皮功能 coronary artery disease: a in Hyperhomocysteinemia of Coronary 影响的临床随机对照研究 randomized controlled clinical Artery Disease trial 【摘要】目的 To Abstract:Objective 观察血府逐 study the Abstract:Objectives To study the intervention function of Xuefu Zhuyu 瘀汤联合西药治疗冠心病高 clinical effect of Xuefu Zhuyu Decoction combined western medicine on Decoction combined with western 同型半胱氨酸血症的临床疗 medicine in endothelial function in 效及其对血管内皮功能的影 hyperhomocysteinemia of Hyperhomocysteinemia of coronary artery coronary artery disease and its disease.Method 80 patients with 响。方法efficacy on将80例冠心病高 endothelial function. Hyperhomocysteinemia of coronary artery 同型半胱氨酸血症患者随机 Methods Eighty patients with disease were divided into treatment group hyperhomocysteinemia of 分为治疗组与对照组,每组 coronary artery disease were and control group,40 cases in each group 。The two groups were all given 40例。两组均予单硝酸异山 divided into treatment and control groups, with 40 cases in each Isosorbide Mononitrate Tablets and 梨酯缓释片、阿司匹林肠溶 group. The two groups were both Aspirin Enteric-coated Tablets,the 片口服,对照组加用叶酸片 given Isosorbide Mononitrate control group were add in Folic Acid,the Tablets and Aspirin Enteric-coated ,治疗组加用血府逐瘀汤。 treatment group were add in Xuefu Zhuyu Tablets, with additional Folic Decoction。 Acid for the control group and Xuefu Zhuyu Decoction for the treatment group respectively. 两组疗程均为3个 The Period of treatment of With an intervention of three all groups were three months, the serum 月,观察监测治疗 months,and then observe levels of Hcy, NO, 前后受试者的血清 the levels of Hcy、 NO、 iNOS, SOD, MDA, Hcy、NO、iNOS、 iNOS、SOD、MDA、 vWF and Ps in SOD、MDA、 vWF、Ps in plasma after subjects were observed being treated.Result ① before and after the vWF、Ps水平的 Within the group after treatment. Results ① 情况。结果 ①治 treatment,the differences For pre and post 疗前后组内比较, of the levels of Hcy plasma treatment comparison 两组同型半胱氨酸 all have statistical within each group, significance(P<0.05); there was statistical 水平差异均有统计 comparison between significance in the 学意义(P< groups after treatment, differences of the Hcy 0.05);组间治疗 the Hcy levels difference levels (P<0.05); for 后比较,同型半胱 was statistically significant comparison between ,the treatment group is groups after treatment, 氨酸水平差异有统 better than the control the (changes of )Hcy 计学意义,治疗组 group (P<0.05); levels in the treatment 优于对照组(P< group were lower than those in the control 0.05)。 group (P<0.05). ② For Intra-group comparison: ②治疗前后组内比较,两组 ②Within the group after treatment, significant difference was NO、iNOS、SOD、MDA、 the differences of the levels of NO、 observed between the levels vWF、Ps水平差异均有统计 of NO, iNOS, SOD, MDA, iNOS、SOD、MDA、vWF、Ps all vWF and Ps (P<0.05) prior to have statistical significance (P<0.05), 学意义(P<0.05);组间治 and after intervention; for comparison between groups after 疗后比较,NO、iNOS、SOD、 group comparison after treatment,the NO、iNOS、SOD、 MDA、vWF、Ps水平差异有 treatment: the levels of NO, MDA、vWF、Ps levels difference wer 统计学意义,治疗组优于对照 iNOS, SOD, MDA, vWF and statistically significant,the treatment Ps in the treatment group 组(P<0.05)。结论 血府逐 group is better than the control group were significantly lower than (P<0.05)。Conclusions The treatment 瘀汤联合西药治疗冠心病高同 those in the control group of Hyperhomocysteinemia of 型半胱氨酸血症,疗效满意, (P<0.05). Conclusion Xuefu Coronary Artery Disease by Xuefu 可显著改善患者的血管内皮功 Zhuyu Decoction combined western Zhuyu Decoction with western medicine was effective in 能,降低血清同型半胱氨酸水 improving the endothelial medicine was satisfactory ,which can 平。 function and reducing the significantly improve the endothelial serum homocysteine levels in function of patients,and reduce the patients with serum homocysteine levels。 hyperhomocysteinemia of coronary artery disease.